PE
CLB icon

Point72 Europe’s Core Laboratories CLB Stock Holding History

Point72 Europe’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$9.54K Buy
+772
New +$9.05K ﹤0.01% 535

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Point72 Europe's CLB Position: Q3 2025 in Review

Point72 Europe opened a new position in Core Laboratories (CLB) in Q3 2025: 772 shares worth $9.54K. The stake represents ﹤0.01% of the portfolio and ranks #535 among its holdings.

190 funds tracked by Wall St. Rank hold CLB as of Q3 2025.

  • Point72 Europe held 772 shares of Core Laboratories worth $9.54K as of Q3 2025.
  • Core Laboratories was a new Point72 Europe position in Q3 2025.
  • Core Laboratories made up ﹤0.01% of Point72 Europe's portfolio in Q3 2025, its #535 holding.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2025.

Based on Point72 Europe's 13F filing for Q3 2025, filed 14 Nov 2025.